Skip navigation

Chemical Gonadal Steroid Hormones

1–50 of 2,269 results.
  Chemical Phenotype Co-Mentioned Terms Interaction Organisms Anatomy Inference Network References
1. 11-ketotestosterone androgen receptor signaling pathway 11-ketotestosterone results in increased androgen receptor signaling pathway 1: Gnathopogon caerulescens Sertoli Cells 1 gene: AR 1
2. 11-ketotestosterone locomotory behavior 11-ketotestosterone affects locomotory behavior 1: Danio rerio     1
3. 11-ketotestosterone androgen metabolic process bisphenol A [bisphenol A affects androgen metabolic process] which results in increased abundance of 11-ketotestosterone 1: Gobiocypris rarus Tissues 1 gene: ESR1 1
4. 16-hydroxyandrost-4-en-3,17-dione steroid biosynthetic process Colforsin [Colforsin results in increased steroid biosynthetic process] which results in increased secretion of 16-hydroxyandrost-4-en-3,17-dione 1: Homo sapiens Adrenal Cortex | Cell Line, Tumor   1
5. 16-hydroxyestrone estrogen biosynthetic process Fingolimod Hydrochloride [Fingolimod Hydrochloride affects estrogen biosynthetic process] which results in decreased secretion of 16-hydroxyestrone 1: Homo sapiens Prostate | Cell Line, Tumor   1
6. 17,20-dihydroxy-4-pregnen-3-one androgen receptor signaling pathway 17,20-dihydroxy-4-pregnen-3-one results in increased androgen receptor signaling pathway 1: Gnathopogon caerulescens Sertoli Cells   1
7. 17-alpha-Hydroxypregnenolone C21-steroid hormone metabolic process Ketoconazole [Ketoconazole affects C21-steroid hormone metabolic process] which results in decreased abundance of 17-alpha-Hydroxypregnenolone 1: Homo sapiens Adrenal Cortex | Cell Line, Tumor   1
8. 17-alpha-Hydroxypregnenolone C21-steroid hormone metabolic process Ketoconazole [Ketoconazole affects C21-steroid hormone metabolic process] which results in decreased abundance of 17-alpha-Hydroxypregnenolone 1: Homo sapiens Adrenal Cortex | Cell Line   1
9. 17-alpha-Hydroxypregnenolone C21-steroid hormone metabolic process Fluconazole [Fluconazole affects C21-steroid hormone metabolic process] which results in decreased abundance of 17-alpha-Hydroxypregnenolone 1: Homo sapiens Adrenal Cortex | Cell Line, Tumor   1
10. 17-alpha-Hydroxypregnenolone C21-steroid hormone metabolic process Fluconazole [Fluconazole affects C21-steroid hormone metabolic process] which results in decreased abundance of 17-alpha-Hydroxypregnenolone 1: Homo sapiens Adrenal Cortex | Cell Line   1
11. 17-alpha-Hydroxypregnenolone steroid biosynthetic process Colforsin [Colforsin results in increased steroid biosynthetic process] which results in increased secretion of 17-alpha-Hydroxypregnenolone 1: Homo sapiens Adrenal Cortex | Cell Line, Tumor 1 gene: CYP17A1 1
12. 17-alpha-Hydroxypregnenolone negative regulation of steroid hormone biosynthetic process Tramadol [Tramadol results in increased negative regulation of steroid hormone biosynthetic process] which results in decreased abundance of 17-alpha-Hydroxypregnenolone 1: Homo sapiens Adrenal Cortex | Cell Line, Tumor   1
13. 17-alpha-Hydroxypregnenolone steroid biosynthetic process Promethazine [Promethazine affects steroid biosynthetic process] which results in increased chemical synthesis of 17-alpha-Hydroxypregnenolone 1: Homo sapiens Adrenal Cortex | Cell Line, Tumor 1 gene: CYP17A1 1
14. 17-alpha-Hydroxypregnenolone steroid biosynthetic process Cetirizine [Cetirizine affects steroid biosynthetic process] which results in increased chemical synthesis of 17-alpha-Hydroxypregnenolone 1: Homo sapiens Adrenal Cortex | Cell Line, Tumor 1 gene: CYP17A1 1
15. 17-alpha-Hydroxypregnenolone steroid biosynthetic process fexofenadine [fexofenadine affects steroid biosynthetic process] which affects the chemical synthesis of 17-alpha-Hydroxypregnenolone 1: Homo sapiens Adrenal Cortex | Cell Line, Tumor 1 gene: CYP17A1 1
16. 17-alpha-Hydroxypregnenolone steroid biosynthetic process Atorvastatin [Atorvastatin results in decreased steroid biosynthetic process] which results in decreased abundance of 17-alpha-Hydroxypregnenolone 1: Homo sapiens Adrenal Cortex | Cell Line, Tumor 1 gene: CYP17A1 1
17. 17-alpha-Hydroxypregnenolone steroid biosynthetic process Atorvastatin [Atorvastatin results in decreased steroid biosynthetic process] which results in decreased abundance of 17-alpha-Hydroxypregnenolone 1: Rattus norvegicus Testis 1 gene: CYP17A1 1
18. 17-alpha-Hydroxypregnenolone steroid biosynthetic process Atorvastatin [Atorvastatin results in decreased steroid biosynthetic process] which results in decreased abundance of 17-alpha-Hydroxypregnenolone 1: Rattus norvegicus Adrenal Glands 1 gene: CYP17A1 1
19. 17-alpha-Hydroxyprogesterone C21-steroid hormone metabolic process Ketoconazole [Ketoconazole affects C21-steroid hormone metabolic process] which results in decreased abundance of 17-alpha-Hydroxyprogesterone 1: Homo sapiens Adrenal Cortex | Cell Line   1
20. 17-alpha-Hydroxyprogesterone C21-steroid hormone metabolic process Ketoconazole [Ketoconazole affects C21-steroid hormone metabolic process] which results in decreased abundance of 17-alpha-Hydroxyprogesterone 1: Homo sapiens Adrenal Cortex | Cell Line, Tumor   1
21. 17-alpha-Hydroxyprogesterone C21-steroid hormone metabolic process Fluconazole [Fluconazole affects C21-steroid hormone metabolic process] which affects the abundance of 17-alpha-Hydroxyprogesterone 1: Homo sapiens Adrenal Cortex | Cell Line, Tumor   1
22. 17-alpha-Hydroxyprogesterone C21-steroid hormone metabolic process Fluconazole [Fluconazole affects C21-steroid hormone metabolic process] which results in increased abundance of 17-alpha-Hydroxyprogesterone 1: Homo sapiens Adrenal Cortex | Cell Line   1
23. 17-alpha-Hydroxyprogesterone steroid biosynthetic process Colforsin [Colforsin results in increased steroid biosynthetic process] which results in increased secretion of 17-alpha-Hydroxyprogesterone 1: Homo sapiens Adrenal Cortex | Cell Line, Tumor
3 genes: CYP11A1 | CYP17A1 | CYP21A2
1
24. 17-alpha-Hydroxyprogesterone negative regulation of steroid hormone biosynthetic process Venlafaxine Hydrochloride [Venlafaxine Hydrochloride results in increased negative regulation of steroid hormone biosynthetic process] which results in decreased abundance of 17-alpha-Hydroxyprogesterone 1: Homo sapiens Adrenal Cortex | Cell Line, Tumor   1
25. 17-alpha-Hydroxyprogesterone negative regulation of steroid hormone biosynthetic process Tramadol [Tramadol results in increased negative regulation of steroid hormone biosynthetic process] which results in decreased abundance of 17-alpha-Hydroxyprogesterone 1: Homo sapiens Adrenal Cortex | Cell Line, Tumor   1
26. 17-alpha-Hydroxyprogesterone steroid biosynthetic process Atorvastatin [Atorvastatin results in decreased steroid biosynthetic process] which results in decreased abundance of 17-alpha-Hydroxyprogesterone 1: Homo sapiens Adrenal Cortex | Cell Line, Tumor
3 genes: CYP11A1 | CYP17A1 | CYP21A2
1
27. 17-alpha-Hydroxyprogesterone steroid biosynthetic process Atorvastatin [Atorvastatin results in decreased steroid biosynthetic process] which results in decreased abundance of 17-alpha-Hydroxyprogesterone 1: Rattus norvegicus Testis
3 genes: CYP11A1 | CYP17A1 | CYP21A2
1
28. 17-alpha-Hydroxyprogesterone steroid biosynthetic process Atorvastatin [Atorvastatin results in decreased steroid biosynthetic process] which results in decreased abundance of 17-alpha-Hydroxyprogesterone 1: Rattus norvegicus Adrenal Glands
3 genes: CYP11A1 | CYP17A1 | CYP21A2
1
29. 17-alpha-Hydroxyprogesterone steroid biosynthetic process Atorvastatin [Atorvastatin results in decreased steroid biosynthetic process] which results in decreased abundance of 17-alpha-Hydroxyprogesterone 1: Rattus norvegicus Plasma
3 genes: CYP11A1 | CYP17A1 | CYP21A2
1
30. 17-alpha-Hydroxyprogesterone positive regulation of lipid storage 1-Methyl-3-isobutylxanthine | Dexamethasone | INS | Rosiglitazone 17-alpha-Hydroxyprogesterone inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased positive regulation of lipid storage] 1: Homo sapiens Subcutaneous Fat | Stem Cells | Cells, Cultured   1
31. 17-alpha-Hydroxyprogesterone positive regulation of lipid storage 1-Methyl-3-isobutylxanthine | INS | Rosiglitazone [17-alpha-Hydroxyprogesterone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased positive regulation of lipid storage 1: Homo sapiens Subcutaneous Fat | Stem Cells | Cells, Cultured   1
32. 17-alpha-Hydroxyprogesterone negative regulation of fat cell differentiation 1-Methyl-3-isobutylxanthine | INS | Rosiglitazone [17-alpha-Hydroxyprogesterone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased negative regulation of fat cell differentiation 1: Homo sapiens Subcutaneous Fat | Stem Cells | Cells, Cultured
2 genes: ADIPOQ | TNF
1
33. 17 alpha-Hydroxyprogesterone Caproate positive regulation of lipid storage 1-Methyl-3-isobutylxanthine | Dexamethasone | INS | Rosiglitazone 17 alpha-Hydroxyprogesterone Caproate inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased positive regulation of lipid storage] 1: Homo sapiens Subcutaneous Fat | Stem Cells | Cells, Cultured   1
34. 17 alpha-Hydroxyprogesterone Caproate positive regulation of lipid storage 1-Methyl-3-isobutylxanthine | INS | Rosiglitazone [17 alpha-Hydroxyprogesterone Caproate co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased positive regulation of lipid storage 1: Homo sapiens Subcutaneous Fat | Stem Cells | Cells, Cultured   1
35. 17 alpha-Hydroxyprogesterone Caproate negative regulation of fat cell differentiation 1-Methyl-3-isobutylxanthine | INS | Rosiglitazone [17 alpha-Hydroxyprogesterone Caproate co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased negative regulation of fat cell differentiation 1: Homo sapiens Subcutaneous Fat | Stem Cells | Cells, Cultured
3 genes: ADIPOQ | IL6 | TNF
1
36. 17-dihydroequilenin lipoprotein oxidation 17-dihydroequilenin results in decreased lipoprotein oxidation 1: Homo sapiens Plasma   1
37. 19-hydroxy-4-androstene-3,17-dione steroid biosynthetic process Colforsin [Colforsin results in increased steroid biosynthetic process] which results in increased secretion of 19-hydroxy-4-androstene-3,17-dione analog 1: Homo sapiens Adrenal Cortex | Cell Line, Tumor   1
38. 2-hydroxyestradiol positive regulation of cell proliferation 2-hydroxyestradiol affects positive regulation of cell proliferation 1: Homo sapiens Prostate | Epithelial Cells | Cell Line
4 genes: AR | CCND1 | MYC | PTGS2
1
39. 2-hydroxyestradiol negative regulation of intracellular estrogen receptor signaling pathway 2-hydroxyestradiol affects negative regulation of intracellular estrogen receptor signaling pathway 1: Homo sapiens Prostate | Epithelial Cells | Cell Line   1
40. 2-hydroxyestradiol positive regulation of dopamine receptor signaling pathway 2-hydroxyestradiol results in increased positive regulation of dopamine receptor signaling pathway Corpus Striatum   1
41. 2-Methoxyestradiol apoptotic process 2-Methoxyestradiol results in increased apoptotic process 1: Homo sapiens Jurkat Cells
10 genes: AKT1 | BAD | BCL2 | CASP3 | CASP7 | CASP8 | CASP9 | CDK1 | PARP1 | XIAP
1
42. 2-Methoxyestradiol apoptotic process TYMP TYMP inhibits the reaction [2-Methoxyestradiol results in increased apoptotic process] 1: Homo sapiens Jurkat Cells
10 genes: AKT1 | BAD | BCL2 | CASP3 | CASP7 | CASP8 | CASP9 | CDK1 | PARP1 | XIAP
1
43. 2-Methoxyestradiol cell proliferation 2-Methoxyestradiol results in decreased cell proliferation 1: Homo sapiens Aorta | Myocytes, Smooth Muscle
11 genes: AKT1 | BAD | BCL2 | CDC25C | CDK1 | CDK4 | CTF1 | CTNNB1 | CYP1A1 | NANOG | VEGFA
1
44. 2-Methoxyestradiol apoptotic process 2-Methoxyestradiol results in increased apoptotic process 1: Homo sapiens Aorta | Myocytes, Smooth Muscle
10 genes: AKT1 | BAD | BCL2 | CASP3 | CASP7 | CASP8 | CASP9 | CDK1 | PARP1 | XIAP
1
45. 2-Methoxyestradiol apoptotic process Thymidine Thymidine inhibits the reaction [2-Methoxyestradiol results in increased apoptotic process] 1: Homo sapiens Aorta | Myocytes, Smooth Muscle
10 genes: AKT1 | BAD | BCL2 | CASP3 | CASP7 | CASP8 | CASP9 | CDK1 | PARP1 | XIAP
1
46. 2-Methoxyestradiol cell cycle 2-Methoxyestradiol results in decreased cell cycle 1: Homo sapiens Aorta | Myocytes, Smooth Muscle
11 genes: CCNA2 | CCNB1 | CCND1 | CCND3 | CCNE2 | CDC25C | CDK1 | CDK2 | CDK4 | CDKN1B | H2AFX
1
47. 2-Methoxyestradiol regulation of membrane permeability Glucose 2-Methoxyestradiol inhibits the reaction [Glucose affects regulation of membrane permeability] 2: Homo sapiens | Mus musculus Brain | Microvessels | Endothelial Cells | Cells, Cultured   1
48. 2-Methoxyestradiol cell proliferation Cadmium Chloride 2-Methoxyestradiol promotes the reaction [Cadmium Chloride results in decreased cell proliferation] 1: Homo sapiens Bronchi | Epithelial Cells | Cell Line
11 genes: AKT1 | BAD | BCL2 | CDC25C | CDK1 | CDK4 | CTF1 | CTNNB1 | CYP1A1 | NANOG | VEGFA
1
49. 2-Methoxyestradiol superoxide dismutase activity Curcumin [2-Methoxyestradiol co-treated with Curcumin] results in decreased superoxide dismutase activity 1: Mus musculus Embryonic Structures | Stem Cells 1 gene: SOD2 1
50. 2-Methoxyestradiol superoxide dismutase activity LIF [2-Methoxyestradiol co-treated with LIF protein] results in decreased superoxide dismutase activity 1: Mus musculus Embryonic Structures | Stem Cells 1 gene: SOD2 1
1–50 of 2,269 results.